Man X - Search Results

1

The Therapeutic Effectiveness of Neoadjuvant Trastuzumab Plus Chemotherapy for HER2-Positive Breast Cancer Can Be Predicted by Tumor-Infiltrating Lymphocytes and PD-L1 Expression.

Shang M, Chi Y, Zhang J, Chang J, Yang H, Yin S, Tan Q, Man X, Li H. Shang M, et al. Among authors: man x. Front Oncol. 2022 Jan 5;11:706606. doi: 10.3389/fonc.2021.706606. eCollection 2021. Front Oncol. 2022. PMID: 35070953 Free PMC article.

2

Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer.

Tan Q, Yin S, Zhou D, Chi Y, Man X, Li H. Tan Q, et al. Among authors: man x. Front Oncol. 2022 Apr 29;12:779786. doi: 10.3389/fonc.2022.779786. eCollection 2022. Front Oncol. 2022. PMID: 35646659 Free PMC article. Review.

3

Efficacy and safety of pyrotinib-containing regimen in the patients with HER2-positive metastatic breast cancer: A multicenter real-world study.

Yin S, Chi Y, Du Y, Wang J, Shan C, Yi W, Shang M, Man X, Tan Q, Li H. Yin S, et al. Among authors: man x. Cancer Med. 2023 Feb;12(3):2333-2344. doi: 10.1002/cam4.5056. Epub 2022 Jul 27. Cancer Med. 2023. PMID: 35894763 Free PMC article.

4

Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database.

Man X, Xu H, Wang H, Zhao J, Chen X, Yin S, Tan Q, Huang J, Sun S, Zhou D, Zheng F, Liu T, Song L, Zhang B, Li N, Li H. Man X, et al. Ann Transl Med. 2022 Dec;10(24):1351. doi: 10.21037/atm-22-5701. Ann Transl Med. 2022. PMID: 36660717 Free PMC article.

5

Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer.

Tan Q, Chi Y, Su M, Zhou J, Zhou D, Zheng F, Man X, Sun S, Huang J, Li H. Tan Q, et al. Among authors: man x. Front Genet. 2023 Mar 16;14:1125970. doi: 10.3389/fgene.2023.1125970. eCollection 2023. Front Genet. 2023. PMID: 37007962 Free PMC article.

6

The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages.

Sun S, Man X, Zhou D, Zheng F, Zhao J, Chen X, Liu T, Huang J, Tan Q, Li N, Li H. Sun S, et al. Among authors: man x. Cancer Med. 2023 Sep;12(18):18850-18860. doi: 10.1002/cam4.6509. Epub 2023 Sep 8. Cancer Med. 2023. PMID: 37688399 Free PMC article.

7

Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study.

Huang J, Sun S, Tan Q, Zheng F, Zhou D, Man X, Hu Y, Li W, Song L, Zhang B, Xu L, Wang X, Xie X, Li H. Huang J, et al. Among authors: man x. Clin Breast Cancer. 2024 Aug;24(6):e509-e518.e1. doi: 10.1016/j.clbc.2024.04.001. Epub 2024 Apr 6. Clin Breast Cancer. 2024. PMID: 38729821 Free article.

8

Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial.

Man X, Huang J, Sun S, Zhou D, Zhang B, Fang S, Zheng F, Li C, Wang X, Huang W, Wang L, He Q, Fu H, Zhang Y, Liu C, Dong L, Zhao X, Xu L, Sun X, Fan B, Song L, Zhou Z, Yu J, Li H. Man X, et al. Clin Transl Med. 2024 May;14(5):e1687. doi: 10.1002/ctm2.1687. Clin Transl Med. 2024. PMID: 38738791 Free PMC article. Clinical Trial.

9

Identification of significant single-nucleotide polymorphisms associated with breast cancer recurrence and metastasis using GWAS.

Sun S, Yin S, Huang J, Zhou D, Tan Q, Man X, Wang W, Zhang J, Li H. Sun S, et al. Among authors: man x. Cancer Innov. 2025 Jan 7;4(1):e142. doi: 10.1002/cai2.142. eCollection 2025 Feb. Cancer Innov. 2025. PMID: 39777116 Free PMC article.

10

miR-301a-mediated crosstalk between the Hedgehog and HIPPO/YAP signaling pathways promotes pancreatic cancer.

Qi B, Wang Y, Zhu X, Gong Y, Jin J, Wu H, Man X, Liu F, Yao W, Gao J. Qi B, et al. Among authors: man x. Cancer Biol Ther. 2025 Dec;26(1):2457761. doi: 10.1080/15384047.2025.2457761. Epub 2025 Jan 23. Cancer Biol Ther. 2025. PMID: 39846248 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

461 results

Search Page

Filters